about
Interferon Regulatory Factor 1 (IRF-1) induces p21(WAF1/CIP1) dependent cell cycle arrest and p21(WAF1/CIP1) independent modulation of survivin in cancer cellsSanguinarine suppresses prostate tumor growth and inhibits survivin expressionProteolytic cleavage of Livin (ML-IAP) in apoptotic melanoma cells potentially mediated by a non-canonical caspaseTargeting Cell Survival Proteins for Cancer Cell DeathDirect interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosisSurvivin mediates resistance to antiandrogen therapy in prostate cancerSurvivin as a target for new anticancer interventionsTargeting survivin in cancer therapyAberrant regulation of survivin by the RB/E2F family of proteinsThe Survivin saga goes in vivoThe tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidneyDimethoxy Curcumin Induces Apoptosis by Suppressing Survivin and Inhibits Invasion by Enhancing E-Cadherin in Colon Cancer Cellsαvβ6 Integrin Promotes Castrate-Resistant Prostate Cancer through JNK1-Mediated Activation of Androgen Receptor.Survivin modulates microtubule dynamics and nucleation throughout the cell cycle.Localization, dynamics, and function of survivin revealed by expression of functional survivinDsRed fusion proteins in the living cell.Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma.Differential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublinesGeneration of a novel transgenic mouse model for bioluminescent monitoring of survivin gene activity in vivo at various pathophysiological processes: survivin expression overlaps with stem cell markersWNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death3,3'-diindolylmethane enhances the efficacy of butyrate in colon cancer prevention through down-regulation of survivinA role for survivin in chemoresistance of endothelial cells mediated by VEGFDevelopment of replication-competent adenovirus for bladder cancer by controlling adenovirus E1a and E4 gene expression with the survivin promoterTargeting apoptosis in cancer chemotherapy.Inhibition of apoptosis by survivin improves transplantation of pancreatic islets for treatment of diabetes in miceMYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductaseInhibition of JAK2 signaling by TG101209 enhances radiotherapy in lung cancer models.A time to kill: targeting apoptosis in cancer.Differential effect of phosphorylation-defective survivin on radiation response in estrogen receptor-positive and -negative breast cancer.Tumor-specific gene expression using the survivin promoter is further increased by hypoxiaRole of the Survivin gene in pathophysiologyRNA interference-mediated survivin gene knockdown induces growth arrest and reduced migration of vascular smooth muscle cells.Survivin, versatile modulation of cell division and apoptosis in cancer.Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma.The role of survivin in diagnosis, prognosis and treatment of breast cancer.Survivin-targeting Artificial MicroRNAs Mediated by Adenovirus Suppress Tumor Activity in Cancer Cells and Xenograft ModelsSoluble-E-cadherin activates HER and IAP family members in HER2+ and TNBC human breast cancers.Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis.Expression and significance of new inhibitor of apoptosis protein survivin in hepatocellular carcinoma.Survivin: a bifunctional inhibitor of apoptosis protein.Mammalian target of rapamycin (mTOR) inhibition in chronic lymphocytic B-cell leukemia: a new therapeutic option.
P2860
Q24300739-9E0D0B56-DA19-4763-9822-606BE4C38CD7Q24628733-C758DA45-1CC9-4974-B6D4-0933279D177CQ24656141-15794A23-6658-43A5-8E9B-DE35668E2F5BQ26765447-AA396F9C-83BA-40E1-9C5D-518D15AC7C0AQ28186614-3AC4E89C-F51A-4C2D-A0D0-BB0873B3428AQ28237159-6408A181-AC39-4433-8EDE-F27203009092Q28257235-6C425372-2563-422B-8DE9-6EC73D87484FQ28273083-73D01F9D-86FE-4292-A3F6-FF141FA07564Q28273531-4B59150E-205E-48E4-972B-765CD8F77E01Q28360685-5F5ECC00-5D5A-446F-9356-25732EAAB41CQ28581878-0DE28139-4EC8-40F8-9AE5-863FD3330BF7Q28830416-8D001D64-F4D4-4B8F-9874-A785828C001DQ30276295-8351D3F6-69B1-4B71-B774-94407AA450F1Q30476873-B326A60B-6E57-41B7-A177-1730FE0EB80DQ30881604-4368F07F-D899-4328-A298-266F935F3000Q33634679-08EA287C-69EE-4807-881F-F7A31E2B1B66Q33646953-C184E07F-A608-45BB-AAEE-08C2F2115976Q33745108-B70585E7-DC37-42BE-AD70-1D8228119A32Q33913340-C4676F1B-44B1-48B0-A440-FD0DF318D8FAQ33980057-1068F706-E849-47EE-A862-C34A1BB13AE6Q34047896-202D6A2C-D544-42C1-BFB3-3AF253F7D2CDQ34221639-B9B39513-F54D-4C87-A993-376151EA19C8Q34568964-1F6480A0-F5F2-4636-AD92-F28249748478Q34590343-11632469-6B28-453F-BE5C-1FCD33F93D11Q34687185-D2A5985F-4462-4043-972D-2E8876333B45Q35013694-4C014CAB-E353-45C1-AF33-2D3FEBE0A8D2Q35138968-71C5DCE7-52FE-45A7-870E-01DBA9D1B572Q35170677-722A840B-FEAC-4C56-9FA5-3AAAD5D36FF4Q35184871-59D16EA7-6170-4886-AB87-43A7A445D098Q35221844-B3DE7CF5-3405-481B-A804-70C4F4E6A7EBQ35543472-FBE84057-39BB-45C2-94D0-66BC734187AAQ35591693-516C3DD7-F7AB-42BB-9B5B-C26166EFA6E8Q35623772-6EA7A54D-C80A-4170-A8C1-17EBBF47172CQ35667653-A2060440-694B-492C-899B-087E95114D08Q35694238-0199CDFF-16E4-43B1-BB5B-2A9B547660D9Q35770840-FFB4A0AE-638F-4205-8D19-37AD2640B9A7Q35834685-C7F53EAE-1A41-43B0-8AEA-EC9106FDC8C0Q35858983-ED2170FF-9D98-4376-ABAF-C84E04763D83Q35959085-B8D98FB7-668E-4E6D-AB18-229588CB69EBQ35994885-BCA8ECAA-DC58-4224-BDF2-D0BEAF431ABA
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cancer gene therapy using a survivin mutant adenovirus
@ast
Cancer gene therapy using a survivin mutant adenovirus
@en
Cancer gene therapy using a survivin mutant adenovirus
@nl
type
label
Cancer gene therapy using a survivin mutant adenovirus
@ast
Cancer gene therapy using a survivin mutant adenovirus
@en
Cancer gene therapy using a survivin mutant adenovirus
@nl
prefLabel
Cancer gene therapy using a survivin mutant adenovirus
@ast
Cancer gene therapy using a survivin mutant adenovirus
@en
Cancer gene therapy using a survivin mutant adenovirus
@nl
P2093
P2860
P3181
P1476
Cancer gene therapy using a survivin mutant adenovirus
@en
P2093
P2860
P304
P3181
P356
10.1172/JCI12983
10.1172/JCI200112983
P407
P577
2001-10-01T00:00:00Z